Literature DB >> 10579123

Th1/Th2 cells.

S Romagnani1.   

Abstract

A large body of evidence indicates the existence of functionally polarized CD4+ T-cell responses based on their profile of cytokine secretion. Type 1 T helper (Th1) cells produce interferon-gamma, interleukin (IL)-2, and tumour necrosis factor (TNF)-beta, which activate macrophages and are responsible for cell-mediated immunity and phagocyte-dependent protective responses. By contrast, type 2 Th (Th2) cells produce IL-4, IL-5, IL-10, and IL-13, which are responsible for strong antibody production, eosinophil activation, and inhibition of several macrophage functions, thus providing phagocyte-independent protective responses. Th1 cells mainly develop following infections by intracellular bacteria and some viruses, whereas Th2 cells predominate in response to infestations by gastrointestinal nematodes. Polarized Th1 and Th2 cells not only exhibit different functional properties, but also show the preferential expression of some activation markers and distinct transcription factors. Several mechanisms may influence the Th cell differentiation, which include the cytokine profile of "natural immunity" evoked by different offending agents, the nature of the peptide ligand, as well as the activity of some costimulatory molecules and microenvironmentally secreted hormones, in the context of the individual genetic background. In addition to playing different roles in protection, polarized Th1-type and Th2-type responses are also responsible for different types of immunopathological reactions. Th1 cells are involved in the pathogenesis of organ-specific autoimmune disorders, Crohn's disease, Helicobacter pylori-induced peptic ulcer, acute kidney allograft rejection, and unexplained recurrent abortions. In contrast, allergen-specific Th2 responses are responsible for atopic disorders in genetically susceptible individuals. Moreover, Th2 responses against still unknown antigens predominate in Omenn's syndrome, idiopathic pulmonary fibrosis, and progressive systemic sclerosis. Finally, the prevalence of Th2 responses may play some role in a more rapid evolution of human immunodeficiency virus infection to the full-blown disease. The Th1/Th2 paradigm also provides the rationale for the development of new types of vaccines against infectious agents and of novel strategies for the therapy of allergic and autoimmune disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10579123     DOI: 10.1097/00054725-199911000-00009

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  116 in total

1.  Tumor necrosis factor inhibitor-associated dermatomyositis.

Authors:  Rachel Klein; Misha Rosenbach; Ellen J Kim; Brian Kim; Victoria P Werth; Jonathan Dunham
Journal:  Arch Dermatol       Date:  2010-07

2.  A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.

Authors:  Nrupen A Bhavsar; Jay H Bream; Alan K Meeker; Charles G Drake; Sarah B Peskoe; Djeneba Dabitao; Angelo M De Marzo; William B Isaacs; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-22       Impact factor: 4.254

3.  Persistent effects on bovine granulosa cell transcriptome after resolution of uterine disease.

Authors:  Rachel L Piersanti; Anthony D Horlock; Jeremy Block; José E P Santos; I Martin Sheldon; John J Bromfield
Journal:  Reproduction       Date:  2019-07       Impact factor: 3.906

Review 4.  The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

Authors:  M Nadeem Khan; Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.

Authors:  Naihan Chen; Monica M Johnson; Michael A Collier; Matthew D Gallovic; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2018-02-02       Impact factor: 9.776

6.  Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.

Authors:  Ana M Espino; Daricel Torres; Adelaida Morales; Bonnibel Delgado; Julia Quetel; Antonio Osuna
Journal:  Exp Parasitol       Date:  2007-03-27       Impact factor: 2.011

7.  Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production.

Authors:  David T Chang; Jacqueline A Jones; Howard Meyerson; Erica Colton; Il Keun Kwon; Takehisa Matsuda; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2008-12-01       Impact factor: 4.396

8.  Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.

Authors:  A Armuzzi; T Ahmad; K-L Ling; A de Silva; S Cullen; D van Heel; T R Orchard; K I Welsh; S E Marshall; D P Jewell
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

9.  Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Authors:  Shao-Ping Liu; Wei-Guo Dong; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.

Authors:  Isabel Fernández de Castro; María Guzmán-Fulgencio; Mónica García-Alvarez; Salvador Resino
Journal:  Crit Care       Date:  2010-02-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.